QXO (QXO) had the highest return between December 25, 2023 and January 8, 2024 by a large-cap US stock, returning 73.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
QXO (QXO) | 12/25/2023 - 1/8/2024 | 73.08% |
Summit Therapeutics (SMMT) | 12/25/2023 - 1/8/2024 | 25.85% |
Moderna (MRNA) | 12/25/2023 - 1/8/2024 | 19.76% |
Emera (EMA) | 12/25/2023 - 1/8/2024 | 10.94% |
argenx NV ADR (ARGX) | 12/25/2023 - 1/8/2024 | 10.77% |
Trip Group Ltd ADR (TCOM) | 12/25/2023 - 1/8/2024 | 10.64% |
Ascendis Pharma A-S (ASND) | 12/25/2023 - 1/8/2024 | 10.4% |
Teva Pharma Industries Ltd ADR (TEVA) | 12/25/2023 - 1/8/2024 | 10.18% |
Super Micro Computer (SMCI) | 12/25/2023 - 1/8/2024 | 10.1% |
Globalstar, Inc Common Stock (GSAT) | 12/25/2023 - 1/8/2024 | 10% |
Eli Lilly and (LLY) | 12/25/2023 - 1/8/2024 | 9.93% |
Viatris (VTRS) | 12/25/2023 - 1/8/2024 | 9.85% |
Grupo Cibest (CIB) | 12/25/2023 - 1/8/2024 | 9.64% |
Ferrovial SE (FER) | 12/25/2023 - 1/8/2024 | 9.52% |
Amgen (AMGN) | 12/25/2023 - 1/8/2024 | 9.42% |
Flex (FLEX) | 12/25/2023 - 1/8/2024 | 9.32% |
Merck (MRK) | 12/25/2023 - 1/8/2024 | 9.19% |
Novartis AG ADR (NVS) | 12/25/2023 - 1/8/2024 | 8.75% |
Allstate (ALL) | 12/25/2023 - 1/8/2024 | 8.72% |
Corebridge Financial (CRBG) | 12/25/2023 - 1/8/2024 | 8.61% |
Nu (NU) | 12/25/2023 - 1/8/2024 | 7.89% |
Match (MTCH) | 12/25/2023 - 1/8/2024 | 7.89% |
Ciena (CIEN) | 12/25/2023 - 1/8/2024 | 7.56% |
GlaxoSmithKline PLC ADR (GSK) | 12/25/2023 - 1/8/2024 | 7.48% |
Mizuho Financial (MFG) | 12/25/2023 - 1/8/2024 | 7.14% |
Large-cap stocks are treated as having a market cap of $10B+.